Case Report
Published on 30 Sep 2025
Case Report: A case of reversible pulmonary bullae induced by camrelizumab: a new immune-related adverse event
in Cancer Immunity and Immunotherapy
- 214 views
Case Report
Published on 30 Sep 2025
in Cancer Immunity and Immunotherapy
General Commentary
Published on 30 Sep 2025
in Health Economics
Correction
Published on 30 Sep 2025
in Cellular Biochemistry
Original Research
Published on 30 Sep 2025
in Chemical Biology
Correction
Published on 30 Sep 2025
in Health Communication
Original Research
Published on 30 Sep 2025
in Cancer Immunity and Immunotherapy
Frontiers in Science Viewpoint
Published on 30 Sep 2025
Original Research
Published on 30 Sep 2025
in Exercise Physiology
Case Report
Published on 30 Sep 2025
in Cardiovascular Imaging
Original Research
Published on 30 Sep 2025
in Water and Critical Zone
Original Research
Published on 30 Sep 2025
in Aquatic Microbiology
Review
Published on 30 Sep 2025
in Translational Pharmacology
Methods
Published on 30 Sep 2025
in Research Methods
Original Research
Published on 30 Sep 2025
in Psychology in Education
Original Research
Published on 30 Sep 2025
in Aging and Public Health
Original Research
Published on 30 Sep 2025
in Reproduction